Amarin Corporation
AMRN
#7825
Rank
C$0.46 B
Marketcap
C$22.57
Share price
-1.04%
Change (1 day)
42.72%
Change (1 year)

P/E ratio for Amarin Corporation (AMRN)

P/E ratio as of January 2026 (TTM): -3.90

According to Amarin Corporation 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.90238. At the end of 2024 the company had a P/E ratio of -2.45.

P/E ratio history for Amarin Corporation from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-2.45
2022-4.52-103.47%
2021130-259.78%
2020-81.5-73.39%
2019-306777.67%
2018-34.9
2016-7.51229.9%
2015-2.28-25.65%
2014-3.06

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
AbbVie
ABBV
164-4,291.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
31.2-900.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
14.5-470.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
GlaxoSmithKline
GSK
14.1-460.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
50.9-1,405.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.